CLMS Ex-Dividend Reminder - 5/12/15

Looking at the universe of stocks we cover at Dividend Channel, on 5/12/15, Calamos Asset Management Incorporated (CLMS) will trade ex-dividend, for its quarterly dividend of $0.15, payable on 5/28/15. As a percentage of CLMS's recent stock price of $12.32, this dividend works out to approximately 1.22%, so look for shares of Calamos Asset Management Incorporated to trade 1.22% lower — all else being equal — when CLMS shares open for trading on 5/12/15.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for CLMS, showing historical dividends prior to the most recent $0.15 declared by Calamos Asset Management Incorporated:

CLMS+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from CLMS is likely to continue, and whether the current estimated yield of 4.87% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of CLMS shares, versus its 200 day moving average:

Calamos Asset Management Incorporated 200 Day Moving Average Chart

Looking at the chart above, CLMS's low point in its 52 week range is $11.15 per share, with $14.44 as the 52 week high point — that compares with a last trade of $12.35.

In Friday trading, Calamos Asset Management Incorporated shares are currently up about 0.5% on the day.

More from Stocks

Banks Prepare to Up Shareholder Payouts By $30 Billion

Banks Prepare to Up Shareholder Payouts By $30 Billion

Starbucks Just Revealed Some of the Most Worrying Data in Its History

Starbucks Just Revealed Some of the Most Worrying Data in Its History

Dow Plunges on Trade War Worries but Walmart and Verizon Finish Positively

Dow Plunges on Trade War Worries but Walmart and Verizon Finish Positively

Trump's Tariff Attack Hasn't Brought Pain to These Hot Stocks

Trump's Tariff Attack Hasn't Brought Pain to These Hot Stocks

Biotech Firm Sarepta Surges 40% on Positive Test Results

Biotech Firm Sarepta Surges 40% on Positive Test Results